Friday, Jun 9, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Business | Dr Reddys Laboratories Launch Generic Epilepsy Drug In Us Market

Dr Reddy’s Laboratories launch generic epilepsy drug in US market

With a CGT designation, the company has a 180-day CGT exclusivity to market this product, he added.

By PTI
Published Date - 07:44 PM, Tue - 2 February 21
Dr Reddy’s Laboratories launch generic epilepsy drug in US market
File Photo.
whatsapp facebook twitter telegram

New Delhi: Dr Reddy’s Laboratories on Tuesday said it has launched Vigabatrin tablets, an antiepileptic drug, in the US market. The Hyderabad-based drug major said it has launched the drug in the American market after receiving approval from the US Food and Drug Administration (USFDA).

“We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA,” Dr Reddy’s Laboratories North America Generics CEO Marc Kikuchi said in a statement.

With a CGT designation, the company has a 180-day CGT exclusivity to market this product, he added. The company’s product is a generic version of Sabril tablets.

As per the IMS Health data, the Sabril brand and its generics had sales of around USD 141 million for the most recent 12 months ending December last year.

  • Follow Us :
  • Tags
  • Dr Reddy’s Laboratories
  • Hyderabad-based
  • Marc Kikuchi
  • US Food and Drug Administration (USFDA)

Related News

  • Rupee rises 4 paise to 81.75 against US dollar

    Rupee rises 4 paise to 81.75 against US dollar

  • Rupee falls 6 paise to 82.01 against US dollar

    Rupee falls 6 paise to 82.01 against US dollar

  • Sensex declines 54.08 points to 60,076.63 points in early trade

    Sensex declines 54.08 points to 60,076.63 points in early trade

  • Hilarious meme fest starts as Twitter removes legacy blue tick

    Hilarious meme fest starts as Twitter removes legacy blue tick

  • PhonePe reaches USD 1 trillion annualised payment value run rate; gets payment aggregator licence

    PhonePe reaches USD 1 trillion annualised payment value run rate; gets payment aggregator licence

  • DRL arm to acquire certain products of Australia-based Mayne Pharma Group

    DRL arm to acquire certain products of Australia-based Mayne Pharma Group

Latest News

  • CM KCR striving for welfare of downtrodden: Errabelli

    3 mins ago
  • Youngsters compete to take selfies at Mancherial’s new IDOC

    4 mins ago
  • Hyderabad: Women techie ends life by jumping from multi-storied building in Shamshabad

    7 mins ago
  • Telangana aims poor to lead life with self-respect: Gangula Kamalakar

    12 mins ago
  • Telangana government striving for BC’s welfare: Puvvada

    17 mins ago
  • Hyderabad Scientists Conserving Bats | The Bat Family

    22 mins ago
  • Trump indicted in classified documents case in a historic first for former president

    23 mins ago
  • Union Bank of India conducts Mega outreach campaign in Hyderabad

    26 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam